CVS HEALTH Corp (CVS)
Retail-Drug Stores and Proprietary Stores · Retail-Drug Stores and Proprietary Stores · NYSE
$97.23
-0.38%
Investru Score
49.6 / 100
Neutral
Why is CVS moving?
CVS is down 0.38% today, amid an otherwise sideways trend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
CVS’s Investru Score changed +2.3 points recently. Want to know exactly what changed and why? That’s a Pro feature →
Score breakdown
- Financial Quality
- 62
- Growth
- 37
- Profitability
- 33
- Balance Sheet
- 33
- Valuation
- 61
- Momentum
- 77
Score history
+2.3 over the last 2 days, driven mainly by momentum (+25).
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- Data unavailable
- ROE
- 2.4%
- FCF Margin
- 1.9%
- Free Cash Flow (TTM)
- $7.8B
- Earnings Quality (OCF ÷ Net Income)
- 6.0x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- 41.6x
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- Data unavailable
- Company Median PEG
- Data unavailable
- Price / Sales
- 0.3x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 6.3%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $2.31
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-08-05
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-05-06
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-10
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-10-29
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-07-31
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-12
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-07
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-08
- 10-K · FY21 · period ended 2021-12-31Filed 2022-02-09
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $123.6B · 52-week range $69.51–$110.68 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2026-08-05
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze CVS with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.